NASDAQ · Healthcare · Biotechnology
Alamar Biosciences, Inc.
ALMR
Alamar Biosciences is a commercial-stage proteomics company focused on ultra-sensitive, multiplexed protein detection for research and future clinical applications. CEO Justin J. McAnear · Market cap $232.8M.
$24.83
+1.86 · +8.10%
52w hi $27.2052w lo $21.50
Off 52w high 0.8%
69
NOTABLE
Current InsiderScore
Corp · 90d
2
2 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
2
0 strong · 2 notable
Analyst consensus
—
—
Section 01
Recent Form 4 filings
2 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Apr 20 | Illumina Innovation Fund II GP, L.L.C. | Buy | 235,294 | $17.00 | +$4.00M | 69 | |
| Apr 20 | Nicholas Naclerio | Buy | 235,294 | $17.00 | +$4.00M | 65 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay